Evolus (EOLS) EBITDA Margin (2019 - 2026)
Evolus (EOLS) recorded EBITDA Margin of -7.21% in Q3 2026, up 6.14 percentage points from -13.36% a year earlier but down 5.07 percentage points from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) EBITDA Margin (2019 - 2026) Analysis & Trends
On a TTM basis, Evolus' EBITDA Margin came in at -1.46% as of Sep 30, 2026, up 9.50 percentage points year-over-year; for FY2025, it came in at -8.03%, up 2.47 percentage points from FY2024.
- Annual EBITDA Margin has increased for three straight years, with a five-year change of +245.51 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -10.50% in FY2024 (+10.77 pp), -21.27% in FY2023 (+19.45 pp), -40.72% in FY2022 (-2.76 pp) and -37.97% in FY2021 (+215.57 pp).
- Quarterly EBITDA Margin has ranged from -54.42% in Q2 2022 to 7.55% in Q4 2025 over the past five years.
- On a year-over-year basis, EBITDA Margin has increased for five consecutive quarters, with an average year-over-year change of +6.03 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 463.28 percentage points in Q4 2021, against a drop of 126.57 percentage points in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -2.14% (Q2 2026), -5.66% (Q1 2026) and 7.55% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Evolus | 455.33 Mn | 264.84 Mn | 50.69 Mn | -7.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -7.21% |
| Jun 30, 2026 | -2.14% |
| Mar 31, 2026 | -5.66% |
| Dec 31, 2025 | 7.55% |
| Sep 30, 2025 | -13.36% |
| Jun 30, 2025 | -11.76% |
| Mar 31, 2025 | -19.42% |
| Dec 31, 2024 | -0.81% |
| Sep 30, 2024 | -23.08% |
| Jun 30, 2024 | -8.96% |
| Mar 31, 2024 | -12.20% |
| Dec 31, 2023 | -11.46% |
| Sep 30, 2023 | -23.72% |
| Jun 30, 2023 | -27.54% |
| Mar 31, 2023 | -25.26% |
| Dec 31, 2022 | -21.37% |
| Sep 30, 2022 | -49.28% |
| Jun 30, 2022 | -54.42% |
| Mar 31, 2022 | -42.06% |
| Dec 31, 2021 | -49.19% |
API Access
Evolus EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();